The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund
Finance

Adaptive Phage Therapeutics Extends Series B to $61 million with Addition of The AMR Action Fund

APR 4, 2022
Researchers identify potential approaches to modify the vaginal microbiome
Pharma & Human Health

Researchers identify potential approaches to modify the vaginal microbiome

MAR 30, 2022
How insights from the field of advanced therapy medicinal products (ATMPs) can inform solutions in the microbiome field
Finance

How insights from the field of advanced therapy medicinal products (ATMPs) can inform solutions in the microbiome field

MAR 23, 2022
A new photoactive viral vector for anti-cancer therapy has been developed
GMO & Synbio

A new photoactive viral vector for anti-cancer therapy has been developed

MAR 15, 2022
Pherecydes Pharma and BIOASTER Join Forces in the Treatment of Bacteremia
Finance

Pherecydes Pharma and BIOASTER Join Forces in the Treatment of Bacteremia

MAR 14, 2022
Deciphering gut microbiome ‘chatter’ to combat IBD
Gastrointestinal

Deciphering gut microbiome ‘chatter’ to combat IBD

MAR 14, 2022
SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark
Finance

SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark

MAR 9, 2022
Microbiotica raises $67M to advance pipeline of microbiome-based therapeutics
Finance

Microbiotica raises $67M to advance pipeline of microbiome-based therapeutics

MAR 9, 2022
Researchers discover unique lysin capable of killing deadly multidrug-resistant bacteria
Infectious Disease & AMR

Researchers discover unique lysin capable of killing deadly multidrug-resistant bacteria

FEB 20, 2022
A new strategy for editing DNA within microbial communities using CRISPR-Cas9 technology
Editor's Choice

A new strategy for editing DNA within microbial communities using CRISPR-Cas9 technology

FEB 18, 2022
Recipharm acquires Arranta Bio
Finance

Recipharm acquires Arranta Bio

FEB 18, 2022